Lansoprazole
Drugoral lansoprazole (1 mg/kg per day, max. 30 mg bid)for 14 day
NCT Number: NCT06964334
Helicobacter pylori (H. pylori) is one of the most common chronic infections worldwide. The mode of transmission of H. pylori is through the fecal-oral or oral-oral routes.
Chronic gastritis has been linked to helicobacter pylori (H. pylori) infection. Peptic ulcer disease, gastric adenocarcinoma, and gastric lymphoma are all linked to this condition .
In Egypt, a high prevalence of H. pylori infections has been reported, ranging from 70% in the general population , 73% among school children , up to 88% in patients with chronic active HCV .
In 2007, the American College of Gastroenterology estimated that the cure rate for H. pylori infections was 70-85 percent with the use of a proton pump inhibitor (PPI), clarithromycin, and amoxicillin or metronidazole .
children with H. pylori infection do not have severe digestive symptoms. pylori infection represents a key factor in the pathogenesis of duodenal ulcer and chronic gastritis in children. In addition, H. pylori infection has also been reported to have extra-digestive consequences .
A recent comprehensive evaluation found that sequential and conventional triple treatment had a cure rate of 84% .
The infected macrophage is unable to create enough 1,25-(OH)2D to control the synthesis of AMP cathelicidin when it is vitamin D deficient .
vitamin D has a powerful systemic antibacterial impact by enhancing the activity of monocytes and macrophages. Most illnesses seem to benefit from a vitamin D-rich condition .
Vitamin D-deficient subjects might be more prone to developing H. pylori infection .
Trial opening soon.
Get Notified1 year–18 year
All sexes
Interventional
Phase 3
To assess the efficacy of adding vitamin D supplement as adjuvant therapy in eliminating helicobacter pylori infection.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
oral lansoprazole (1 mg/kg per day, max. 30 mg bid)for 14 day
amoxicillin (50 mg/kg per day, max. 1 g bid) for 14 day
oral clarithromycin (15 mg/kg per day, max. 500 mg bid) for 14 day
vitamin D therapy of 4000-5000 units daily in patients over 12 months old.
Time frame: 3 months
compare cure rate between two groups
Assiut University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07729293
Dyspepsia, Gastrointestinal Adverse Effects
Don Benito, Badajoz, Spain
View Trial DetailsNCT07624422
Digestive System Diseases, Duodenal Diseases
Damascus, Syria
View Trial DetailsNCT07458490
Digestive System Diseases, Duodenal Diseases
View Trial DetailsNCT07405697
Helicobacter Pylori Infection
Shanghai, Shanghai Municipality, China
View Trial Details